• Search

Search in Site

Industry news and analysis across pharma and medical devices PharmaDeviceNews.com

  • Home
  • Pharma & Biotech
  • Medical Devices & Diagnostics
  • Features & Analysis
  • Privacy Policy
  • About PharmaDeviceNews
  • Editorial Policy
  • Disclaimer
  • Contact Us
Home»Posts tagged with»FDA 510k clearance

Can low-dose radiotherapy reshape osteoarthritis care after Siemens Healthineers’ FDA clearance

By Pallavi Madhiraju on March 22, 2026   Medical Devices & Diagnostics  

Can low-dose radiotherapy reshape osteoarthritis care after Siemens Healthineers’ FDA clearance

Siemens Healthineers expands TrueBeam into osteoarthritis care with FDA clearance. Find out how radiotherapy could reshape chronic pain treatment.

What Bayer’s MRXperion 510(k) clearance means for high-field MRI workflow and contrast injection systems

By Pallavi Madhiraju on March 5, 2026   Medical Devices & Diagnostics  

What Bayer’s MRXperion 510(k) clearance means for high-field MRI workflow and contrast injection systems

FDA clears expanded capabilities for Bayer MRXperion MRI injector supporting scanners up to 7T. Discover what this means for imaging workflows and radiology systems.

Why GE HealthCare’s FDA-cleared SIGNA MRI update is more about operations than image quality

By Pallavi Madhiraju on February 20, 2026   Medical Devices & Diagnostics  

Why GE HealthCare’s FDA-cleared SIGNA MRI update is more about operations than image quality

GE HealthCare’s FDA-cleared SIGNA MRI systems signal a shift toward autonomous, helium-free imaging. Explore what this means for MRI operations.

Bimini Health Tech strengthens Puregraft franchise with SYNC as fat grafting scales globally

By Pallavi Madhiraju on February 20, 2026   Medical Devices & Diagnostics  

Bimini Health Tech strengthens Puregraft franchise with SYNC as fat grafting scales globally

Bimini Health Tech secures FDA clearance for Puregraft SYNC. Explore what it changes for fat grafting workflows, adoption economics, and device strategy.

Recent Posts

  • AACR 2026: SAGA Diagnostics pushes Pathlight MRD deeper into metastatic breast and ovarian cancer
  • Agenus AACR 2026 data show immune reprogramming signal in PD-1 refractory gastroesophageal cancer
  • AACR 2026: Can Zai Lab’s zocilurtatug pelitecan change the treatment picture for small cell lung cancer brain metastases?
  • How JANX014 expands Janux Therapeutics’ tumor-activated platform strategy in prostate cancer immunotherapy
  • What Medicus Pharma Ltd.’s SkinJect application signals for Hedgehog pathway-driven cancers
  • Why Bioxodes’ adaptive trial strategy could accelerate approval timelines in stroke therapeutics
  • What Kura Oncology’s latest data reveals about resistance biology in kidney cancer
  • Can Fate Therapeutics, Inc. solve the conditioning chemotherapy problem in CAR T?
  • Could Ampligen become a late-stage pancreatic cancer breakthrough after AIM ImmunoTech’s latest clinical push?
  • What the new J-code means for Glaukos’ Epioxa launch and the future of keratoconus reimbursement
  • Molgramostim review pushed to November: what Savara’s FDA delay means for autoimmune PAP
  • What SurGenTec’s TiLink navigation clearance means for surgeons using minimally invasive SI joint fusion systems
    • About PharmaDeviceNews
    • Contact Us
    • Disclaimer
    • Editorial Policy
    • Privacy Policy
© 2026, ↑ PharmaDeviceNews
Log in - Powered by WordPress - Gabfire Themes